Report overview
This report contains market size and forecasts of Anti-Retroviral Drugs in global, including the following market information:
Global Anti-Retroviral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti-Retroviral Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Anti-Retroviral Drugs companies in 2021 (%)
The global Anti-Retroviral Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Protease Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Retroviral Drugs include Cardionet, GE Healthcare, Abbott, AstraZeneca, Bristol-Myers-Squibb, Gilead, Cardiac Science Corp., Cardiocom and Biotelemetry, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Retroviral Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Retroviral Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Anti-Retroviral Drugs Market Segment Percentages, by Type, 2021 (%)
Protease Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Integrase Inhibitors
Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
Global Anti-Retroviral Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Anti-Retroviral Drugs Market Segment Percentages, by Application, 2021 (%)
Hepatitis
HIV/AIDS
Herpes
Influenza
Others
Global Anti-Retroviral Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Anti-Retroviral Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Retroviral Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti-Retroviral Drugs revenues share in global market, 2021 (%)
Key companies Anti-Retroviral Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Anti-Retroviral Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cardionet
GE Healthcare
Abbott
AstraZeneca
Bristol-Myers-Squibb
Gilead
Cardiac Science Corp.
Cardiocom
Biotelemetry
GlaxoSmithKline
Roche
